Amundi Purchases 61,796 Shares of Axcelis Technologies, Inc. $ACLS

Key Points

• Amundi increased its stake in Axcelis Technologies by 12.6%, acquiring 61,796 shares, bringing its total holdings to 551,047 shares valued at about $27.37 million.
• Analysts have recently boosted Axcelis Technologies' target price, with DA Davidson increasing it from $75 to $90, reflecting a positive outlook for the stock.
• Axcelis reported a quarterly revenue of $194.54 million, surpassing estimates, although its earnings per share (EPS) decreased year-over-year to $1.13 from $1.55.

Amundi boosted its position in shares of Axcelis Technologies, Inc. (NASDAQ:ACLS - Free Report) by 12.6% during the 1st quarter, according to the company in its most recent filing with the SEC. The institutional investor owned 551,047 shares of the semiconductor company's stock after buying an additional 61,796 shares during the quarter. Amundi owned approximately 1.72% of Axcelis Technologies worth $27,371,000 as of its most recent SEC filing.

A number of other large investors also recently made changes to their positions in the stock. Vanguard Group Inc. increased its position in shares of Axcelis Technologies by 1.0% in the 1st quarter. Vanguard Group Inc. now owns 4,439,902 shares of the semiconductor company's stock valued at $220,530,000 after buying an additional 43,768 shares in the last quarter. Reinhart Partners LLC. increased its holdings in Axcelis Technologies by 39.1% during the 1st quarter. Reinhart Partners LLC. now owns 1,441,022 shares of the semiconductor company's stock worth $71,576,000 after purchasing an additional 404,910 shares in the last quarter. American Century Companies Inc. increased its holdings in Axcelis Technologies by 7.6% during the 1st quarter. American Century Companies Inc. now owns 1,140,495 shares of the semiconductor company's stock worth $56,648,000 after purchasing an additional 80,399 shares in the last quarter. Boston Trust Walden Corp boosted its stake in shares of Axcelis Technologies by 0.8% during the 1st quarter. Boston Trust Walden Corp now owns 826,332 shares of the semiconductor company's stock worth $41,044,000 after buying an additional 6,216 shares during the last quarter. Finally, BlackBarn Capital Partners LP boosted its stake in shares of Axcelis Technologies by 758.0% during the 1st quarter. BlackBarn Capital Partners LP now owns 480,441 shares of the semiconductor company's stock worth $23,864,000 after buying an additional 424,444 shares during the last quarter. Institutional investors and hedge funds own 89.98% of the company's stock.

Axcelis Technologies Trading Down 1.3%

Shares of NASDAQ:ACLS traded down $1.09 during mid-day trading on Friday, reaching $85.27. 75,456 shares of the company's stock were exchanged, compared to its average volume of 612,670. The firm has a market capitalization of $2.68 billion, a price-to-earnings ratio of 17.47 and a beta of 1.73. The business's fifty day moving average price is $77.16 and its 200-day moving average price is $64.11. The company has a debt-to-equity ratio of 0.04, a quick ratio of 4.26 and a current ratio of 6.01. Axcelis Technologies, Inc. has a twelve month low of $40.40 and a twelve month high of $110.17.

Axcelis Technologies (NASDAQ:ACLS - Get Free Report) last released its earnings results on Tuesday, August 5th. The semiconductor company reported $1.13 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.73 by $0.40. The business had revenue of $194.54 million for the quarter, compared to analyst estimates of $185.15 million. Axcelis Technologies had a net margin of 17.69% and a return on equity of 16.26%. Axcelis Technologies's revenue for the quarter was down 24.2% on a year-over-year basis. During the same quarter in the previous year, the business earned $1.55 earnings per share. Axcelis Technologies has set its Q3 2025 guidance at 1.000-1.000 EPS. On average, research analysts predict that Axcelis Technologies, Inc. will post 2.55 EPS for the current fiscal year.

Analyst Upgrades and Downgrades

Several brokerages recently issued reports on ACLS. DA Davidson raised their target price on shares of Axcelis Technologies from $75.00 to $90.00 and gave the company a "buy" rating in a research note on Wednesday, August 6th. B. Riley raised their price objective on shares of Axcelis Technologies from $58.00 to $75.00 and gave the stock a "neutral" rating in a research report on Wednesday, June 18th. Two analysts have rated the stock with a Buy rating and four have assigned a Hold rating to the company. According to MarketBeat.com, the company currently has a consensus rating of "Hold" and a consensus target price of $90.00.

Axcelis Technologies Profile

Axcelis Technologies, Inc designs, manufactures, and services ion implantation and other processing equipment used in the fabrication of semiconductor chips in the United States, Europe, and Asia Pacific. The company offers high energy, high current, and medium current implanters for various application requirements.